FES for Foot Drop in MS: A Practical Guide to Orthotic vs. Therapeutic Effects

This brief breaks down a recent high-quality study on Functional Electrical Stimulation (FES) for foot drop in MS. We'll look at the difference between immediate (orthotic) and long-term (therapeutic) effects, helping you set realistic expectations and optimize treatment for your patients.

Research: February 2026

Key Findings

1New FES users primarily show therapeutic effects (motor learning) over weeks, not immediate orthotic improvement.
2Long-term FES users demonstrate strong orthotic effects (immediate improvement with the device on) but limited further therapeutic gains.
3An initial decrease in unassisted dorsiflexion can occur in new users, suggesting an adaptation period is required.
4Individualized FES parameter setting by a trained professional is critical for optimal outcomes.
5Improvements in walking speed and step length are seen in both short- and long-term users, but the mechanism (therapeutic vs. orthotic) differs.

Hey colleagues, let's talk about FES for foot drop in our MS population. We all use it, but a fascinating 2026 longitudinal study from a top German research group (Heidelberg University Hospital) sheds new light on what’s actually happening when we strap these devices on. This wasn't a massive study, but it was well-designed, giving us some moderate-quality evidence to chew on. The researchers looked at two groups: new FES users and those who had been using it for over a year. The big takeaway? The effects are surprisingly different depending on how long the patient has been using the device. For new users, the study found significant *therapeutic* effects. After a trial period, their unassisted walking improved—they got faster and took longer steps. But here's the kicker: the immediate *orthotic* effect (the improvement seen the second they turn the device on) wasn't that impressive. In fact, their ankle dorsiflexion sometimes got a little worse initially. This tells us there's a motor learning component. Their nervous system is adapting to the stimulation over weeks, not minutes. Now, for the long-term users, it was the opposite story. They showed a strong, immediate *orthotic* response. Turn the device on, and their dorsiflexion at heel strike and during swing phase instantly improved, boosting their speed and step length. However, they didn't show much more therapeutic adaptation. They had already banked those motor learning gains. The protocol was what you'd expect: stimulating the common peroneal nerve with devices like the L300Go or Evomove. A key point is that they didn't use a one-size-fits-all approach. Every patient had their parameters—frequency, pulse width, and electrode placement—customized by a certified orthotist. This is a crucial reminder that individualized setup is paramount.

Clinician's Note

I found this study really validating. We often have that patient who tries FES for a day and says, 'I don't feel a huge difference.' This gives us the language to explain why. It’s not just a brace; it’s a training tool. I now make a point of telling new users to be patient and trust the process for at least 4-6 weeks. It helps manage their expectations and improves buy-in when they understand we're retraining their brain, not just lifting their foot.

Clinic Action Plan

1. Patient Selection: Identify MS patients with foot drop impacting gait safety and efficiency. 2. Device Trial: Secure a trial with a reputable FES device (e.g., L300Go, Evomove). Emphasize this is an assessment period. 3. Professional Fitting: Ensure the device is fitted and parameters are optimized by a certified orthotist or a PT with specialized training. Do not use default settings. 4. Set Expectations (New User): Explain that the primary goal is long-term motor learning. The biggest gains will come from consistent use over several weeks, not just the immediate 'on' effect. 5. Set Expectations (Long-Term User): For experienced users, focus on the device as a functional tool. The goal is the immediate orthotic benefit for safer, more efficient walking. 6. Outcome Measures: Track progress with the 10-Meter Walk Test and a patient-reported outcome measure like the MS Walking Scale (MSWS-12) at baseline and after the trial period. 7. Re-evaluation: Periodically re-assess parameters and device fit, especially if the patient's condition changes.

Common Mistakes to Avoid

•Expecting a huge 'wow' factor on day one for new users. The real magic is the therapeutic change over time.
•Using generic, out-of-the-box FES settings. Individual optimization is non-negotiable.
•Abandoning the trial too early. The study suggests a multi-week trial is necessary to see the true therapeutic potential.
•Failing to distinguish between the orthotic and therapeutic goals when educating the patient.

Frequently Asked Questions

Premium Deep Dive

This brief includes an extended deep-dive section with clinical nuance, dosing details, edge cases, and special population considerations.

Unlock with Premium — $99/yr

GRADE-graded with DOI links Evidence verified

This brief is for educational purposes only. Always verify clinical decisions with peer-reviewed sources and your professional judgment.

Want more from NeuroDash?

Save protocols, track CEU hours, download PDFs, and get unlimited AI access.

Explore Premium — $99/yr

More in MS

HIIT for MS: A Practical Guide to Improving Fatigue and Exercise Capacity

This brief provides a practical, evidence-based guide to implementing High-Intensity Interval Training (HIIT) for patients with Multiple Sclerosis. It covers the why, the how, and the what-to-watch-out-for, so you can confidently prescribe this powerful intervention to improve patient outcomes.

A Practical Guide to Fall Prevention in Multiple Sclerosis

Falls are a serious and frequent problem for people with Multiple Sclerosis, but they are not inevitable. This brief provides practical, evidence-based strategies you can use to significantly reduce fall risk in your patients with MS, focusing on targeted exercise and functional training.

Mastering Gait in MS: A Practical Guide to Task-Oriented Rehab

This brief breaks down how to use task-oriented training to improve walking in your patients with MS. It’s a practical, evidence-based guide to move beyond generic exercises and create targeted interventions that get real results.

Beyond Baclofen: Modern Spasticity Management in MS

This brief outlines practical, evidence-based strategies for managing spasticity in your MS patients. It moves beyond just medication, focusing on targeted physiotherapy and what the latest research says about what really works.

Related Videos